Skip to menu Skip to content Skip to footer

2007

Journal Article

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

2007

Journal Article

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

Vesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

2007

Journal Article

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

2007

Conference Publication

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. World Congress of Nephrology, Rio De Janeiro, Brazil, 21-25 April , 2007. International Society of Nephrology (ISN).

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

2007

Conference Publication

Erythropoietin: Novel applications beyond anaemia treatment

Vesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007.

Erythropoietin: Novel applications beyond anaemia treatment

2007

Conference Publication

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia:

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

2006

Journal Article

Novel renoprotective actions of erythropoietin: New uses for an old hormone

Johnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x

Novel renoprotective actions of erythropoietin: New uses for an old hormone

2006

Journal Article

Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure

Johnson, D. W., Pat, B., Vesey, D. A., Guan, Z., Endre, Z. and Gobe, G. C. (2006). Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney International, 69 (10), 1806-1813. doi: 10.1038/sj.ki.5000356

Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure

2006

Conference Publication

PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells

Li, J., Vesey, D. and Gobe, G. (2006). PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells. Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14–19 August 2006.

PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells

2006

Conference Publication

Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress

Yamada, M., Vesey, D., Johnson, D. W. and Gobe, G. (2006). Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress. ANZSN 2006: 42nd Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14-19 August 2006. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2006.00656.x

Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress

2006

Conference Publication

PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells

Li, Jun, Vesey, David and Gobe, Glenda (2006). PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells. American Society of Nephrology Renal Research Week, San Diego, USA, 2006. ASN.

PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells

2006

Conference Publication

Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways

Rajandram, R ., Pat, B., Li, J., Percy, C. J., Vesey, D., Johnson, D. W. and Gobe, G. C. (2006). Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways. Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Melbourne, Australia, 14-18 August 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2006.00656.x

Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways

2006

Conference Publication

PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses

Gobe, G. C., Johnson, D. W., Kruger, W., Poronnik, P. and Vesey, D. A. (2006). PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses. Renal Week 2006: American Society of Nephrology Annual Meeting, San Diego, California, U.S., 14 - 19 November, 2006. American Society of Nephrology.

PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses

2005

Journal Article

Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells

Vesey, David A., Cheung, Catherine W., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda and Johnson, David W. (2005). Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. Kidney International, 67 (4), 1315-1329. doi: 10.1111/j.1523-1755.2005.00209.x

Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells

2005

Journal Article

Role of protein kinase C and oxidative stress in interleukin-1β-induced human proximal tubule cell injury and fibrogenesis

Vesey, David A., Cheung, Catherine, Endre, Zoltan, Gobe, Glenda and Johnson, David W. (2005). Role of protein kinase C and oxidative stress in interleukin-1β-induced human proximal tubule cell injury and fibrogenesis. Nephrology, 10 (1), 73-80. doi: 10.1111/j.1440-1797.2005.00363.x

Role of protein kinase C and oxidative stress in interleukin-1β-induced human proximal tubule cell injury and fibrogenesis

2005

Conference Publication

Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin

Gobe, G., Yamada, M., Pat, B., Vesey, D. and Johnson, D. W. (2005). Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin

2005

Conference Publication

Resistance to cancer treatments in renal cell carcinoma: Discovering novel apoptosis pathways

Rajandram, R., Pat, B., Li, J., Percy, C., Vesey, D., Johnson, D. W. and Gobe, G. (2005). Resistance to cancer treatments in renal cell carcinoma: Discovering novel apoptosis pathways. 5th Annual Health and Medical Research Conference of Queensland, Brisbane, Queensland, 3-4 November, 2005. Brisbane, Queensland: Queensland Health.

Resistance to cancer treatments in renal cell carcinoma: Discovering novel apoptosis pathways

2005

Conference Publication

The role of JAK tyrosine kinases in renal fibrosis involving oxidative stress

Pat, B., Healy, H., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2005). The role of JAK tyrosine kinases in renal fibrosis involving oxidative stress. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3–7 September 2005. Carlton, VIC: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

The role of JAK tyrosine kinases in renal fibrosis involving oxidative stress

2005

Journal Article

Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas

Cheung, Catherine, Vesey, David, Cotterill, Andrew, Douglas, Meaghan, Gobe, Glenda, Nicol, David and Johnson, David (2005). Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas. International Journal of Urology, 12 (1), 17-28. doi: 10.1111/j.1442-2042.2004.00993.x

Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas

2005

Conference Publication

Delayed bolus administration of darbepoietin or erythropoietin protects against ischaemic acute renal injury and failure

Johnson, D., Pat, B., Vesey, D., Guan, Z., Endre, Z. and Gobe, G. (2005). Delayed bolus administration of darbepoietin or erythropoietin protects against ischaemic acute renal injury and failure. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Delayed bolus administration of darbepoietin or erythropoietin protects against ischaemic acute renal injury and failure